APSA Papers| Volume 46, ISSUE 1, P150-156, January 2011

Elements of successful intestinal rehabilitation



      The optimal therapy for intestinal failure (IF) is unknown. The results of a systematic, protocol-driven management strategy by a multidisciplinary team are described.


      Intestinal failure was defined as bowel length of less than 40 cm or parenteral nutrition (PN) for more than 42 days. A multidisciplinary team and protocol to prevent PN-associated liver disease (PNALD) were instituted in 2006. Data were gathered prospectively with consent and ethics board approval.


      From 1998 to 2006, 33 patients were treated (historical cohort) with an overall survival of 72%. Rotating prophylactic antibiotics for bacterial overgrowth were given to 27% of patients; 6% had lipid-sparing PN, and none received fish oil–based lipids. Median time to intestinal rehabilitation was 7 ± 3.1 months, and 27% of patients who developed PNALD died. From 2006 to 2009, 31 patients were treated. Seventy-seven percent received PAB; 60%, lipid-sparing PN; and 47%, parenteral fish oil emulsion. Eighty-seven percent weaned from PN at 3.9 ± 3.8 months, and no patients developed PNALD with 100% survival. Novel lipid therapies were associated with changes in essential fatty acid profile and one case of clinical essential fatty acid deficiency.


      The institution of a multidisciplinary team and a protocol-driven strategy to prevent PNALD improves survival in IF. Further studies are recommended.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sigalet D.
        • Boctor D.
        • Robertson M.
        • et al.
        Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease.
        Eur J Pediatr Surg. 2009; 19: 348-353
        • Sigalet D.L.
        Short bowel syndrome in infants and children: an overview.
        Semin Pediatr Surg. 2001; 10: 49-55
        • Wales P.W.
        • de Silva N.
        • Kim J.
        • et al.
        Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates.
        J Pediatr Surg. 2004; 39: 690-695
        • Alvarez S.M.
        • Burd R.S.
        Increasing prevalence of gastroschisis repairs in the United States: 1996-2003.
        J Pediatr Surg. 2007; 42: 943-946
        • Molik K.A.
        • Gingalewski C.A.
        • West K.W.
        • et al.
        Gastroschisis: a plea for risk categorization.
        J Pediatr Surg. 2001; 36: 51-55
        • Skarsgard E.D.
        • Claydon J.
        • Bouchard S.
        • et al.
        Canadian Pediatric Surgical Network: a population-based pediatric surgery network and database for analyzing surgical birth defects. The first 100 cases of gastroschisis.
        J Pediatr Surg. 2008; 43: 30-34
        • Uauy R.D.
        • Fanaroff A.A.
        • Korones S.B.
        • et al.
        Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network.
        J Pediatr. 1991; 119: 630-638
        • Diamond I.R.
        • de S.N.
        • Pencharz P.B.
        • et al.
        Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience.
        J Pediatr Surg. 2007; 42: 806-811
        • Modi B.P.
        • Langer M.
        • Ching Y.A.
        • et al.
        Improved survival in a multidisciplinary short bowel syndrome program.
        J Pediatr Surg. 2008; 43: 20-24
        • Torres C.
        • Sudan D.
        • Vanderhoof J.
        • et al.
        Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure.
        J Pediatr Gastroenterol Nutr. 2007; 45: 204-212
        • Meehan J.J.
        • Georgeson K.E.
        Prevention of liver failure in parenteral nutrition–dependent children with short bowel syndrome.
        J Pediatr Surg. 1997; 32: 473-475
        • Quiros-Tejeira R.E.
        • Ament M.E.
        • Reyen L.
        • et al.
        Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience.
        J Pediatr. 2004; 145: 157-163
        • Blau J.
        • Sridhar S.
        • Mathieson S.
        • et al.
        Effects of protein/nonprotein caloric intake on parenteral nutrition associated cholestasis in premature infants weighing 600-1000 grams.
        JPEN J Parenter Enteral Nutr. 2007; 31: 487-490
        • Koehler A.N.
        • Yaworski J.A.
        • Gardner M.
        • et al.
        Coordinated interdisciplinary management of pediatric intestinal failure: a 2-year review.
        J Pediatr Surg. 2000; 35: 380-385
        • Goulet O.J.
        • Revillon Y.
        • Jan D.
        • et al.
        Neonatal short bowel syndrome.
        J Pediatr. 1991; 119: 18-23
        • Duggan C.
        • Piper H.
        • Javid P.J.
        • et al.
        Growth and nutritional status in infants with short-bowel syndrome after the serial transverse enteroplasty procedure.
        Clin Gastroenterol Hepatol. 2006; 4: 1237-1241
        • Modi B.P.
        • Javid P.J.
        • Jaksic T.
        • et al.
        First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications.
        J Am Coll Surg. 2007; 204: 365-371
        • Javid P.J.
        • Kim H.B.
        • Duggan C.P.
        • et al.
        Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome.
        J Pediatr Surg. 2005; 40: 1019-1023
        • Diamond I.R.
        • Sterescu A.
        • Pencharz P.B.
        • et al.
        Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome.
        J Pediatr Gastroenterol Nutr. 2009; 48: 209-215
        • Struijs M.C.
        • Diamond I.R.
        • de S.N.
        • et al.
        Establishing norms for intestinal length in children.
        J Pediatr Surg. 2009; 44: 933-938
        • Spencer A.U.
        • Neaga A.
        • West B.
        • et al.
        Pediatric short bowel syndrome: redefining predictors of success.
        Ann Surg. 2005; 242: 403-409
        • Spencer A.U.
        • Kovacevich D.
        • Kinney-Barnett M.
        • et al.
        Pediatric short-bowel syndrome: the cost of comprehensive care.
        Am J Clin Nutr. 2008; 88: 1552-1559
        • Wales P.W.
        • de Silva N.
        • Kim J.H.
        • et al.
        Neonatal short bowel syndrome: a cohort study.
        J Pediatr Surg. 2005; 40: 755-762
        • Gura K.M.
        • Lee S.
        • Valim C.
        • et al.
        Safety and efficacy of a fish-oil–based fat emulsion in the treatment of parenteral nutrition–associated liver disease.
        Pediatrics. 2008; 121: e678-e686
        • Goulet O.
        • Ruemmele F.
        Causes and management of intestinal failure in children.
        Gastroenterology. 2006; 130: S16-S28
        • Andorsky D.J.
        • Lund D.P.
        • Lillehei C.W.
        • et al.
        Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes.
        J Pediatr. 2001; 139: 27-33
        • Snyder C.L.
        Outcome analysis for gastroschisis.
        J Pediatr Surg. 1999; 34: 1253-1256
        • Agostoni C.
        Role of long-chain polyunsaturated fatty acids in the first year of life.
        J Pediatr Gastroenterol Nutr. 2010; 47: S41-S44
        • Innes S.
        Omega-3 fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations?.
        J Pediatr Gastroenterol Nutr. 2009; 48: S16-S24
        • Fitzgibbons S.C.
        • Jones B.A.
        • Hull M.A.
        • et al.
        The relationship between biopsy proven parenteral nutrition associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome.
        J Pediatr Surg. 2010; 45: 95-99